Trials / Terminated
TerminatedNCT00380783
Safety and Efficacy of AGN 203818 for Pain Associated With Painful Bladder Syndrome/Interstitial Cystitis
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 2 (actual)
- Sponsor
- Allergan · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will explore the safety and effectiveness of different doses of AGN 203818 in treating the pain associated with painful bladder syndrome/interstitial cystitis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AGN 203818 |
Timeline
- Start date
- 2006-10-01
- Primary completion
- 2007-03-01
- Completion
- 2007-03-01
- First posted
- 2006-09-26
- Last updated
- 2011-05-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00380783. Inclusion in this directory is not an endorsement.